A secreted antagonist of TGF-β ligands, Coco, blocks paracrine BMP signaling and downstream GATA3 to enhance the self-renewal capability and reactivation of dormant breast cancer cells in the lungs (Gao et al., 2012). This evidence concerns the gene TGFB1 and breast cancer.